Verition Fund Management’s Cyclo Therapeutics, Inc. Warrant CYTHW Stock Holding History

Verition Fund Management’s Portfolio CYTHW Stock Details CYTHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-800,000	Closed	–	–	3179
2022 Q1	$0	Hold	800,000	–	–	﹤0.01%	3095
2021 Q4	$0	Buy	+800,000	New	+$1.93M	﹤0.01%	2850

Other funds holding CYTHW

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Verition Fund Management's CYTHW Position: Q2 2022 in Review

Verition Fund Management sold out of Cyclo Therapeutics, Inc. Warrant (CYTHW) in Q2 2022, closing a stake of 800,000 shares.

Verition Fund Management first reported a position in CYTHW in Q4 2021 and held it in 2 quarters. The position peaked at $0 in Q1 2022. 3 funds tracked by Wall St. Rank hold CYTHW as of Q2 2022.

Verition Fund Management reported no remaining Cyclo Therapeutics, Inc. Warrant position as of Q2 2022 after selling out during the quarter.
Verition Fund Management sold 800,000 Cyclo Therapeutics, Inc. Warrant shares in Q2 2022.
Verition Fund Management first reported a position in Cyclo Therapeutics, Inc. Warrant in Q4 2021 and held it in 2 quarters.
Verition Fund Management's Cyclo Therapeutics, Inc. Warrant position peaked at $0 in Q1 2022.
3 funds tracked by Wall St. Rank held Cyclo Therapeutics, Inc. Warrant as of Q2 2022.

Based on Verition Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.